Literature DB >> 16759864

Control of iron metabolism in Mycobacterium tuberculosis.

G Marcela Rodriguez1.   

Abstract

Tuberculosis continues to kill millions of people around the world. New tools to prevent and treat this disease are urgently needed. Similar to most microorganisms, Mycobacterium tuberculosis--the causative agent of tuberculosis--requires iron for essential metabolic pathways. Because iron is not freely available in the host, pathogens must actively compete for this metal to establish an infection but they must also carefully control iron acquisition as excess free iron can be extremely toxic. Recent studies have demonstrated that failure to assemble the iron acquisition machinery or to repress iron uptake has deleterious effects for M. tuberculosis. Here, we review how M. tuberculosis obtains iron in a regulated manner and discuss how these processes could potentially be disrupted to interfere with the survival and replication of this bacterium in the host.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16759864     DOI: 10.1016/j.tim.2006.05.006

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  57 in total

1.  Systems biology approaches to understanding mycobacterial survival mechanisms.

Authors:  Helena I M Boshoff; Desmond S Lun
Journal:  Drug Discov Today Dis Mech       Date:  2010

2.  Isoniazid Preventive Therapy in Contacts of Multidrug-Resistant Tuberculosis.

Authors:  Chuan-Chin Huang; Mercedes C Becerra; Roger Calderon; Carmen Contreras; Jerome Galea; Louis Grandjean; Leonid Lecca; Rosa Yataco; Zibiao Zhang; Megan Murray
Journal:  Am J Respir Crit Care Med       Date:  2020-10-15       Impact factor: 21.405

3.  Characterization of heme ligation properties of Rv0203, a secreted heme binding protein involved in Mycobacterium tuberculosis heme uptake.

Authors:  Cedric P Owens; Jing Du; John H Dawson; Celia W Goulding
Journal:  Biochemistry       Date:  2012-02-08       Impact factor: 3.162

4.  A new approach to cyclic hydroxamic acids: Intramolecular cyclization of N-benzyloxy carbamates with carbon nucleophiles.

Authors:  Yuan Liu; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  Tetrahedron       Date:  2011-03-25       Impact factor: 2.457

5.  Purification, crystallization and preliminary X-ray studies of MbtN (Rv1346) from Mycobacterium tuberculosis.

Authors:  Ai Fen Chai; Jodie M Johnston; Richard D Bunker; Esther M M Bulloch; Genevieve L Evans; J Shaun Lott; Edward N Baker
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-11-28

Review 6.  The tuberculosis drug discovery and development pipeline and emerging drug targets.

Authors:  Khisimuzi Mdluli; Takushi Kaneko; Anna Upton
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

Review 7.  Iron Homeostasis in Mycobacterium tuberculosis: Mechanistic Insights into Siderophore-Mediated Iron Uptake.

Authors:  Manjula Sritharan
Journal:  J Bacteriol       Date:  2016-08-25       Impact factor: 3.490

8.  Post-translational Acetylation of MbtA Modulates Mycobacterial Siderophore Biosynthesis.

Authors:  Olivia Vergnolle; Hua Xu; JoAnn M Tufariello; Lorenza Favrot; Adel A Malek; William R Jacobs; John S Blanchard
Journal:  J Biol Chem       Date:  2016-08-26       Impact factor: 5.157

9.  Iron-sparing response of Mycobacterium avium subsp. paratuberculosis is strain dependent.

Authors:  Harish K Janagama; John P Bannantine; Abirami Kugadas; Pratik Jagtap; LeeAnn Higgins; Bruce Witthuhn; Srinand Sreevatsan
Journal:  BMC Microbiol       Date:  2010-10-22       Impact factor: 3.605

10.  Interpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid production.

Authors:  Caroline Colijn; Aaron Brandes; Jeremy Zucker; Desmond S Lun; Brian Weiner; Maha R Farhat; Tan-Yun Cheng; D Branch Moody; Megan Murray; James E Galagan
Journal:  PLoS Comput Biol       Date:  2009-08-28       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.